About Vivodyne
Vivodyne is a company based in Philadelphia (United States) founded in 2021 by Dan Huh.. Vivodyne has raised $117.69 million across 3 funding rounds from investors including Khosla Ventures, CS Ventures and Kairos Ventures. Vivodyne offers products and services including Human Organ Models and Predictive AI. Vivodyne operates in a competitive market with competitors including Newcells Biotech, InSphero, Pandorum, Adapsyn and Cellesce, among others.
- Headquarter Philadelphia, United States
- Founders Dan Huh
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vivodyne, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$117.69 M (USD)
in 3 rounds
-
Latest Funding Round
$77.69 M (USD), Series A
Feb 03, 2025
-
Investors
Khosla Ventures
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vivodyne
Vivodyne offers a comprehensive portfolio of products and services, including Human Organ Models and Predictive AI. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Lab-grown tissues for realistic drug testing simulations
AI platform that optimizes therapies using human data
Unlock access to complete
Funding Insights of Vivodyne
Vivodyne has successfully raised a total of $117.69M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $77.69 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $77.7M
-
First Round
First Round
(11 Mar 2021)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Series A - Vivodyne | Valuation | Khosla Ventures | |
| Nov, 2023 | Amount | Seed - Vivodyne | Valuation | Khosla Ventures | |
| Mar, 2021 | Amount | Seed - Vivodyne | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vivodyne
Vivodyne has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Khosla Ventures, CS Ventures and Kairos Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life sciences, physical sciences, and technology companies
|
Founded Year | Domain | Location | |
|
Investment in start-ups for global impact, with focus on B2B services and software solutions in India.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vivodyne
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vivodyne
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vivodyne Comparisons
Competitors of Vivodyne
Vivodyne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newcells Biotech, InSphero, Pandorum, Adapsyn and Cellesce, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Induced pluripotent stem cell-derived organoid models are developed for research.
|
|
| domain | founded_year | HQ Location |
Cell-based assays and 3D microtissues for drug screening are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine and 3D tissues are developed for therapeutic uses.
|
|
| domain | founded_year | HQ Location |
Provider of computational tools for bacterial metabolomic and genomic data analysis
|
|
| domain | founded_year | HQ Location |
Scalable processes for organoid expansion are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vivodyne
Frequently Asked Questions about Vivodyne
When was Vivodyne founded?
Vivodyne was founded in 2021.
Where is Vivodyne located?
Vivodyne is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Is Vivodyne a funded company?
Vivodyne is a funded company, having raised a total of $117.69M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on Mar 11, 2021.
What does Vivodyne do?
Vivodyne was founded in 2021 in Philadelphia, United States, within the biotechnology sector. An AI-driven platform is utilized to culture human tissue models for drug discovery purposes. Single-cell 4D phenomics is integrated with a confocal microscope, alongside an automated robotic system that identifies potential drugs and cellular therapies. Operations focus on advancing preclinical testing through engineered biological models.
Who are the top competitors of Vivodyne?
Vivodyne's top competitors include Newcells Biotech, InSphero and Parallel Bio.
What products or services does Vivodyne offer?
Vivodyne offers Human Organ Models and Predictive AI.
Who are Vivodyne's investors?
Vivodyne has 8 investors. Key investors include Khosla Ventures, CS Ventures, Kairos Ventures, MBX Capital, and Bison Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.